With the widespread adoption of population-based breast cancer screening, ductal
carcinoma in situ (DCIS) has come to represent 20–25% of all breast neoplastic lesions …

Ductal carcinoma in situ (DCIS) constitutes a major public health problem, with up to half of
screen-detected cancers representing pure forms of DCIS without evidence of invasion. A …

Background Whole breast irradiation (WBI) after conservative surgery for ductal carcinoma
in situ (DCIS) reduces local recurrence. We investigated whether a tumour bed boost after …

Background For women with ductal carcinoma in situ (DCIS) of the breast, the risk of
developing an ipsilateral breast event (IBE; defined as local recurrence of DCIS or invasive …

An estimated 60,290 new cases of breast carcinoma in situ are expected to be diagnosed in
2015, and approximately 1 in 33 women is likely to receive an in situ breast cancer …

Abstract Background In Germany, most breast cancer patients are treated in specialized
breast cancer units (BCU), which are certified, and routinely monitored. Herein, we evaluate …

Purpose: Ductal carcinoma in situ (DCIS) patients and their physicians currently face
challenging treatment decisions with limited information about the individual's subsequent …

The international radiotherapy (RT) expert panel has revised and updated the RT guidelines
that were accepted in 2020 at the 4th Hungarian Breast Cancer Consensus Conference …

Abstract Background The Sloane audit compares screen-detected ductal carcinoma in situ
(DCIS) pathology with subsequent management and outcomes. Methods This was a …

Objective: To assess cause-specific mortality in women treated for ductal carcinoma in situ
(DCIS). Background: From screening and treatment perspective, it is relevant to weigh the …